ClinConnect ClinConnect Logo
Search / Trial NCT05706077

Effects of TDCS and Physical Therapy in Chronic Migraine

Launched by FEDERAL UNIVERSITY OF PARAÍBA · Jan 20, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Physical Therapy Transcranial Direct Current Stimulation Facial Recognition

ClinConnect Summary

This clinical trial is looking at how two different treatments—transcranial Direct Current Stimulation (tDCS) and physical therapy—can help reduce the pain and frequency of chronic migraines in women. The study will involve women aged 18 to 50 who have been diagnosed with chronic migraines. Participants will be placed into one of four groups to see how each treatment affects their migraine symptoms.

To be part of this study, women need to be between 18 and 50 years old, literate, and have chronic migraines. They should not be using a lot of headache medications or receiving any other treatments for their migraines. Participants can expect to be monitored closely and will receive either tDCS, physical therapy, or both to see which method works best for them. It’s important to note that women who are pregnant, have certain health conditions, or have recently changed their migraine medication will not be eligible to join the trial.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women;
  • 18-50 years old;
  • with Chronic Migraine according to ICHD-3 beta;
  • literate;
  • stable on routine medications specific for MC for at least 2 months, who were not undergoing other types of non-pharmacological interventions for MC, not lactating or pregnant, without neurological diseases or serious neuropsychiatric diseases, without other types of associated headaches, without signs and/or symptoms of spinal radiculopathy, without metal implants located in the head and/or cochlear implants.
  • Exclusion Criteria:
  • who perhaps become pregnant during the execution of the clinical trial
  • present some disease that disables their continuity in the treatment
  • start another type of treatment
  • show changes in physical activity and/or eating routine during the research
  • has severe depression (BDI \> 35).

About Federal University Of Paraíba

The Federal University of Paraíba (UFPB) is a renowned academic institution located in Brazil, dedicated to advancing education, research, and innovation in various fields, including health sciences. With a commitment to excellence, UFPB actively engages in clinical trials aimed at contributing to medical knowledge and improving patient care. The university's research initiatives are supported by a multidisciplinary team of experts who collaborate to ensure rigorous ethical standards and scientific validity in their studies. UFPB's clinical trials focus on addressing pressing health challenges, fostering partnerships within the scientific community, and translating research findings into practical applications for the benefit of society.

Locations

João Pessoa, Paraiba, Brazil

Patients applied

0 patients applied

Trial Officials

Renata Aranha

Principal Investigator

Federal University of Paraiba

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials